The increased analyst price target for Goldwind Science & Technology is primarily driven by improved consensus revenue growth forecasts and a lower discount rate, resulting in a fair value revision from CN¥12.70 to CN¥13.60.
What's in the News
- Board approved application for registration and issuance of long-term option-embedded medium-term bonds.
- Board meeting scheduled to review and approve interim results for the six months ended June 30, 2025.
- Board considered appointments for president, vice president, secretary to the board, and company secretary.
- Board meeting held on July 8, 2025.
Valuation Changes
Summary of Valuation Changes for Goldwind Science&Technology
- The Consensus Analyst Price Target has risen from CN¥12.70 to CN¥13.60.
- The Consensus Revenue Growth forecasts for Goldwind Science&Technology has risen slightly from 15.2% per annum to 15.9% per annum.
- The Discount Rate for Goldwind Science&Technology has fallen slightly from 11.91% to 11.58%.
Have other thoughts on Goldwind Science&Technology?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.